2-(o-tolyl)acrylonitrile

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(o-tolyl)acrylonitrile
• 英文别名: 2-(2-Methylphenyl)acrylonitrile；2-(2-methylphenyl)prop-2-enenitrile
• 化学式: C₁₀H₉N
• 分子量: 143.188
• InChiKey: UBLVISZFNNSYBB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  23.8
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-(o-tolyl)acrylonitrile 在 glucose dehydrogenase 、 盐酸 、 D-古洛糖 、 叠氮磷酸二苯酯 、 old yellow enzyme 1 from Saccharomyces pastorianus 、 水 、 还原型辅酶II(NADPH)四钠盐 作用下， 以 二甲基亚砜 、 甲苯 为溶剂， 反应 29.0h， 生成 (R)-O-甲基-A-苯胺
  参考文献：
  名称：

  烯还原酶在水性介质和两相离子液体-水系统中催化（R）-2-芳基丙烯腈的对映选择性合成

  摘要：

  烯还原酶催化的α-亚甲基腈衍生物的对映选择性还原可提供相应的（R）-2-芳基丙腈，并具有较高的转化率。可在水性介质中（与有机助溶剂或通过将底物装载到疏水性树脂上）或在双相离子液体-水系统中研究反应。发现将离子液体与分离的烯还原酶一起使用可改善后处理和底物回收方法。最终手性腈衍生物的合成操作表明如何利用这种生物催化方法制备各种手性化合物。

  DOI：

  10.1002/cctc.201402205
• 作为产物：
  描述：

  2-甲基苯硼酸 、 2-氯丙烯腈 在 bis(η3-allyl-μ-chloropalladium(II)) cis,cis,cis-1,2,3,4-tetrakis (diphenylphosphinomethyl)cyclopentane 、 potassium carbonate 作用下， 以 xylene 为溶剂， 反应 20.0h， 以62%的产率得到2-(o-tolyl)acrylonitrile
  参考文献：
  名称：

  Suzuki Coupling of 2‐Chloroacrylonitrile, Methyl 2‐Chloroacrylate, or 2‐Chloroprop‐1‐en‐3‐ol with Arylboronic Acids Catalyzed by a Palladium‐Tetraphosphine Complex

  摘要：

  The tetraphosphine all-cis-1,2,3,4-tetrakis(diphenylphosphinomethyl) cyclopentane (Tedicyp) in combination with [Pd(C3H5)Cl](2) affords an efficient catalyst of the coupling of 2-chloroacrylonitrile with arylboronic acids. In the presence of 1% catalyst, the 2-arylacrylonitrile derivatives were obtained in medium to good yields. A variety of substituents such as alkyl, methoxy, fluoro, trifluoromethyl, formyl, or nitro on the arylboronic acid are tolerated. The cross-coupling reactions of methyl 2-chloroacrylate with arylboronic acids give simple access to 2-phenylacrylate derivatives, which are useful precursors for the synthesis of biologically active compounds such as ibuprofen, ketoprofen, and naproxen.

  DOI：

  10.1080/00397910600773866

文献信息

• Substituted pyrimidinone and pyridone compounds and methods of use
  申请人：Amgen Inc.

  公开号：US06096753A1

  公开（公告）日：2000-08-01

  Selected novel substituted pyrimidinone and pyridone compounds are effective for prophylaxis and treatment of diseases, such as TNF-.alpha., IL-1.beta., IL-6 and/or IL-8 mediated diseases, and other maladies, such as pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving inflammation, pain, diabetes and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  所选的新型嘧啶酮和吡啶酮化合物对预防和治疗疾病（如TNF-alpha、IL-1beta、IL-6和/或IL-8介导的疾病）以及其他疾病（如疼痛和糖尿病）具有有效性。该发明涵盖了新型化合物、类似物、前药和其药学上可接受的盐，以及用于预防和治疗涉及炎症、疼痛、糖尿病等疾病和其他疾患或情况的药物组合物和方法。该发明还涉及制备这类化合物的方法，以及在这类方法中有用的中间体。
• Substituted pyridine and pyridazine compounds and methods of use
  申请人：Amgen Inc.

  公开号：US06174901B1

  公开（公告）日：2001-01-16

  Selected novel substituted pyridine and pyridazine compounds are effective for prophylaxis and treatment of diseases, such as TNF-&agr;, IL-1&bgr;, IL-6 and/or IL-8 mediated diseases, and other maladies, such as cancer, pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving inflammation, cancer, pain, diabetes and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  选定的小说替代吡啶和吡啶二氮化合物对于预防和治疗疾病，如TNF-α、IL-1β、IL-6和/或IL-8介导的疾病，以及其他疾病，如癌症、疼痛和糖尿病，具有有效性。该发明涵盖了新颖化合物、类似物、前药和其药学上可接受的盐，药物组合物以及用于预防和治疗涉及炎症、癌症、疼痛、糖尿病等疾病和其他疾病或病情的方法。该发明还涉及制备这类化合物的方法以及在这类方法中有用的中间体。
• Substituted indolizine-like compounds and methods of use
  申请人：——

  公开号：US20030195221A1

  公开（公告）日：2003-10-16

  Selected novel substituted indolizine-like compounds are effective for treatment of diseases, such as TNF-&agr;, IL-1&bgr;, IL-6 and/or IL-8 mediated diseases, and other maladies, such as cancer, pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for treatment of diseases and other maladies or conditions involving inflammation, cancer, pain, diabetes and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  选定的类似吲哚啉的化合物对治疗疾病，如TNF-α、IL-1β、IL-6和/或IL-8介导的疾病，以及其他疾病，如癌症、疼痛和糖尿病具有有效性。本发明涵盖了新型化合物、类似物、前药和其药用可接受盐、制药组合物以及治疗涉及炎症、癌症、疼痛、糖尿病等疾病和其他疾患或情况的方法。该发明还涉及制备此类化合物的方法，以及在此类过程中有用的中间体。
• Substituted pyrimidine compounds and methods of use
  申请人：Amgen Inc.

  公开号：US20030069425A1

  公开（公告）日：2003-04-10

  Selected novel substituted pyrimidine compounds are effective for prophylaxis and treatment of diseases, such as TNF-&agr;, IL-1&bgr;, IL-6 and/or IL-8 mediated diseases, and other maladies, such as pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving inflammation, pain, diabetes and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  选择的新型代替嘧啶类化合物可用于预防和治疗诸如TNF-α、IL-1β、IL-6和/或IL-8介导的疾病，以及其他疾病，如疼痛和糖尿病。该发明涵盖了新型化合物、类似物、前药及其药学上可接受的盐、制药组合物和用于预防和治疗涉及炎症、疼痛、糖尿病等疾病和其他疾病或病况的方法。该发明还涉及制备这种化合物的过程，以及在这些过程中有用的中间体。
• Substituted pyridone compounds and methods of use
  申请人：Amgen Inc.

  公开号：US20030073704A1

  公开（公告）日：2003-04-17

  Selected novel substituted pyrimidinone and pyridone compounds are effective for prophylaxis and treatment of diseases, such as TNF-&agr;, IL-1&bgr;, IL-6 and/or IL-8 mediated diseases, and other maladies, such as pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving inflammation, pain, diabetes and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  选定的新型嘧啶酮和吡啶酮化合物对于预防和治疗疾病（如TNF-α、IL-1β、IL-6和/或IL-8介导的疾病）以及其他疾病（如疼痛和糖尿病）是有效的。该发明涵盖了新型化合物、类似物、前药和其药学上可接受的盐、制药组合物以及用于预防和治疗涉及炎症、疼痛、糖尿病等疾病和其他疾患或病况的方法。该发明还涉及制造这些化合物的过程以及在这些过程中有用的中间体。